Processa Pharmaceuticals, Inc. Increase (Decrease) in Receivables
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Receivables of -$25.00 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2017-10-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2017-10-04
- Processa Pharmaceuticals, Inc. increase (decrease) in receivables for the quarter ending 2016-06-30 was $0.00.
- Processa Pharmaceuticals, Inc. increase (decrease) in receivables for the quarter ending 2016-03-31 was -$25.00K.
- Processa Pharmaceuticals, Inc. increase (decrease) in receivables for the quarter ending 2015-12-31 was $1.31K, a 94.85% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in receivables for the quarter ending 2015-09-30 was $83.61K, a 15.66% increase year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in receivables for fiscal 2015 was -$3.84K, a 121.45% decline from fiscal 2014.
- Processa Pharmaceuticals, Inc. increase (decrease) in receivables for fiscal 2014 was $17.89K, a 52.24% increase from fiscal 2013.
- Processa Pharmaceuticals, Inc. increase (decrease) in receivables for fiscal 2013 was $11.75K.
- Processa Pharmaceuticals, Inc. increase (decrease) in receivables for fiscal 2012 was -$24.45K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 3 month as first filed | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 6 month as first filed | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 9 month as first filed | Increase (Decrease) in Receivables 12 month | Increase (Decrease) in Receivables 12 month as first filed | Increase (Decrease) in Receivables 27 month | Increase (Decrease) in Receivables 30 month | Increase (Decrease) in Receivables 33 month | Increase (Decrease) in Receivables 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | -$25.00K 10-Q · filed 2017-10-04 | -$23.69K derived: sum of 3 quarters · filed 2017-10-04 | $59.92K derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2016-03-31 | -$25.00K 10-Q · filed 2017-10-04 | -$23.69K derived: sum of 2 quarters · filed 2017-10-04 | $59.92K derived: sum of 3 quarters · filed 2017-10-04 | $57.38K derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2015-12-31 | $1.31K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $84.92K derived: sum of 2 quarters · filed 2017-09-25 | $82.38K derived: sum of 3 quarters · filed 2017-09-25 | -$3.84K 10-K · filed 2017-09-25 | ||||||||
| 2015-09-30 | $83.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $81.07K derived: sum of 2 quarters · filed 2017-09-08 | -$5.15K 10-Q · filed 2017-09-08 | -$2.36K 10-Q · filed 2015-12-01 | $20.28K derived: sum of 4 quarters · filed 2017-09-08 | |||||||
| 2015-06-30 | -$2.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | -$88.76K 10-Q · filed 2017-08-30 | -$99.73K 10-Q · filed 2015-08-19 | -$63.33K derived: sum of 3 quarters · filed 2017-08-30 | $8.96K derived: sum of 4 quarters · filed 2017-08-30 | |||||||
| 2015-03-31 | -$86.21K 10-Q · filed 2017-08-07 | -$87.27K 10-Q · filed 2015-05-15 | -$60.78K derived: sum of 2 quarters · filed 2017-08-07 | $11.51K derived: sum of 3 quarters · filed 2017-08-07 | -$67.18K derived: sum of 4 quarters · filed 2017-08-07 | |||||||
| 2014-12-31 | $25.43K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $97.72K derived: sum of 2 quarters · filed 2017-06-19 | $19.04K derived: sum of 3 quarters · filed 2017-06-19 | $17.89K 10-K · filed 2017-06-19 | $15.11K 10-K · filed 2015-04-14 | |||||||
| 2014-09-30 | $72.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | -$6.39K derived: sum of 2 quarters · filed 2015-12-01 | -$7.54K 10-Q · filed 2015-12-01 | -$2.34K derived: sum of 4 quarters · filed 2015-12-01 | ||||||||
| 2014-06-30 | -$78.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$79.83K 10-Q · filed 2015-08-19 | -$74.63K derived: sum of 3 quarters · filed 2015-08-19 | -$37.88K derived: sum of 4 quarters · filed 2015-08-19 | ||||||||
| 2014-03-31 | -$1.15K 10-Q · filed 2015-05-15 | $4.05K derived: sum of 2 quarters · filed 2015-05-15 | $40.81K derived: sum of 3 quarters · filed 2015-05-15 | -$645.00 derived: sum of 4 quarters · filed 2015-05-15 | -$23.34K 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | $5.20K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $41.95K derived: sum of 2 quarters · filed 2015-04-14 | $500.00 derived: sum of 3 quarters · filed 2015-04-14 | $11.75K 10-K · filed 2015-04-14 | -$22.20K 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | $36.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$4.70K derived: sum of 2 quarters · filed 2014-11-13 | $6.55K 10-Q · filed 2014-11-13 | -$23.90K derived: sum of 4 quarters · filed 2014-11-13 | -$27.40K 10-Q · filed 2013-11-08 | |||||||
| 2013-06-30 | -$41.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | -$30.20K 10-Q · filed 2014-08-19 | -$60.65K derived: sum of 3 quarters · filed 2014-08-19 | -$25.45K derived: sum of 4 quarters · filed 2014-08-19 | -$64.15K 10-Q/A · filed 2013-09-06 | |||||||
| 2013-03-31 | $11.25K 10-Q · filed 2014-05-14 | -$19.20K derived: sum of 2 quarters · filed 2014-05-14 | $16.00K derived: sum of 3 quarters · filed 2014-05-14 | |||||||||
| 2012-12-31 | -$30.45K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $4.75K derived: sum of 2 quarters · filed 2014-03-27 | -$24.45K 10-K · filed 2014-03-27 | |||||||||
| 2012-09-30 | $35.20K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | $6.00K 10-Q · filed 2013-11-08 | ||||||||||
| 2012-06-30 | -$29.20K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |